May 1, 2020 | News & Media
An approved pilot study is underway that explores the impact of wearing two Fos Biomedical Viral Response devices in combination with orally administered Copper Glycinate (2mg BID) on reducing infectious markers of the blood and antibody markers for COVID-19. In...
Feb 27, 2020 | News & Media
We are delighted to announce that our new brand Purali Therapeutics website is now live. Visit www.puralitherapeutics.com for more information. Purali Therapeutics is a natural pain management product to help those suffering with osteoarthritis pain. ...
Nov 15, 2019 | News & Media
Further Validation of the Chronic Pain Coping Inventory The Chronic Pain Coping Inventory (CPCI), developed to assess coping strategies targeted for change in multidisciplinary pain treatment, is a 64-item instrument that contains 8 subscales: Guarding, Resting,...
Sep 16, 2019 | News & Media
Abstract. This work is supported and managed through the NASA Marshall Space Flight Center – SBIR Program. LED-technology developed for NASA plant growth experiments in space shows promise for delivering light deep into tissues of the body to promote wound...
Aug 19, 2019 | News & Media
Michael R. Hamblin, Ph.D. is a Principal Investigator at Wellman Center for Photomedicine, Massachusetts General Hospital, and an Associate Professor Harvard Medical School. We have followed his work for a number of years as he has interests in photodynamic therapy...
